Dimercaprol Therapy

Dimercaprol Therapy is a chelation treatment modality that specifically involves the administration of dimercaprol, a thiol-containing chelating agent, to bind and facilitate the excretion of toxic heavy metals such as arsenic, mercury, and lead from the body.

80

Publications

2.6K

Citations

232

Authors

93

Institutions

Publications per year

2017–2026

3

Authors

232

  1. WT
    WARFIELD T. LONGCOPE

    Johns Hopkins University, United States

    3 publications · 112 citations

    3

    h-index

  2. HE
    Harry Eagle

    National Institutes of Health, United States

    3 publications · 77 citations

    3

    h-index

  3. JA
    John A. Luetscher

    Stanford University, United States

    3 publications · 112 citations

    3

    h-index

  4. JW
    J.M. Walshe

    University of Cambridge, United Kingdom

    2 publications · 114 citations

    2

    h-index

  5. WJ
    W. J. H. Butterfield

    Guy's Hospital, United Kingdom

    2 publications · 35 citations

    2

    h-index

1–5 of 232

Venues

  1. PubMed

    Repository · 12 publications · 408 citations

    12

    h-index

  2. Journal of Clinical Investigation

    JCI · 7 publications · 265 citations

    7

    h-index

  3. Journal of Toxicology Clinical Toxicology

    5 publications · 124 citations

    5

    h-index

  4. The Lancet

    4 publications · 84 citations

    4

    h-index

  5. Toxicology and Applied Pharmacology

    TAAP · 3 publications · 70 citations

    3

    h-index

1–5